Clinical Trials
Sun Pharma Receives Approval from DCGI to Initiate Clinical Trial with Nafamostat in Covid-19 Patients
Sun Pharma
PR-M06-20-NI-004Jun 02, 2020
FDA Approval
Sun Pharma Announces U.S. FDA Approval of CEQUA™ to Treat Dry Eye Disease
Sun Pharma
PR-M09-18-NI-053Sep 18, 2018
Dermatology
Sun Pharma Announces Twelve Tildrakizumab Abstracts to be Presented at American Academy of Dermatology 2018 Annual Meeting
Sun Pharma
PR-M02-18-NI-54Feb 15, 2018
Partnership
New Partnership to Tackle Challenging Infectious Diseases
Emilie Branch
Pharma's Almanac
PAO-M07-17-NI-005Jul 07, 2017